Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model.
暂无分享,去创建一个
[1] R. K. Jain,et al. Intratumoral infusion of fluid: estimation of hydraulic conductivity and implications for the delivery of therapeutic agents. , 1998, British Journal of Cancer.
[2] V. Grégoire,et al. Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] R K Jain,et al. Barriers to drug delivery in solid tumors. , 1994, Scientific American.
[4] Ricky T. Tong,et al. Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] R K Jain,et al. Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.
[6] R K Jain,et al. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. , 1990, Cancer research.
[7] A. Fischman,et al. Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[8] S. Heiland,et al. Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy. , 2005, Cancer research.
[9] R K Jain,et al. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. , 1992, Cancer research.
[10] R K Jain,et al. Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. , 1989, Microvascular research.
[11] Rakesh K. Jain,et al. Transport of molecules across tumor vasculature , 2004, Cancer and Metastasis Reviews.
[12] Lei Xu,et al. Tumour biology: Herceptin acts as an anti-angiogenic cocktail , 2002, Nature.
[13] J. Wood,et al. Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. , 2000, International journal of oncology.
[14] R. Jain,et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[15] R. Jain,et al. Blood flow and venous pH of tissue-isolated Walker 256 carcinoma during hyperglycemia. , 1988, Cancer research.
[16] Rakesh K. Jain,et al. Pathology: Cancer cells compress intratumour vessels , 2004, Nature.
[17] Satoshi Hirakawa,et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis , 2005, The Journal of experimental medicine.
[18] R. Kirshner,et al. The Earth's elements. , 1994, Scientific American.
[19] R. Jain. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.
[20] R K Jain,et al. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] Dai Fukumura,et al. Peritumor Lymphatics Induced by Vascular Endothelial Growth Factor-C Exhibit Abnormal Function , 2004, Cancer Research.
[22] M Ancukiewicz,et al. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. , 2000, Cancer research.
[23] R K Jain,et al. Transport of fluid and macromolecules in tumors. II. Role of heterogeneous perfusion and lymphatics. , 1990, Microvascular research.
[24] E. Rofstad,et al. Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. , 2002, Cancer research.
[25] Rakesh K. Jain,et al. Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors , 2004, Cancer Research.
[26] T W Gardner,et al. Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties. , 2000, Microvascular research.
[27] R K Jain,et al. Tumor angiogenesis and interstitial hypertension. , 1996, Cancer research.
[28] D. Bates,et al. Evidence of a role for TRPC channels in VEGF-mediated increased vascular permeability in vivo. , 2004, American journal of physiology. Heart and circulatory physiology.
[29] B. Berghuis,et al. Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. , 2006, Cancer research.
[30] R K Jain,et al. Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism. , 1991 .
[31] Dai Fukumura,et al. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. , 2006, Cancer research.
[32] D. Bates,et al. Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels. , 1996, The American journal of physiology.
[33] R. Jain,et al. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. , 2000, Cancer research.
[34] R K Jain,et al. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[35] R K Jain,et al. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. , 1988, Cancer research.
[36] Ricky T. Tong,et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.
[37] Rakesh K Jain,et al. Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.
[38] Tracy T Batchelor,et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. , 2007, Cancer cell.
[39] R. Jain,et al. Measurement of capillary filtration coefficient in a solid tumor. , 1991, Cancer research.
[40] R K Jain,et al. Transport of molecules in the tumor interstitium: a review. , 1987, Cancer research.
[41] R. Skalak,et al. Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery. , 1995, Cancer research.
[42] B Landuyt,et al. Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11 , 2003, British Journal of Cancer.
[43] B. Haraldsson,et al. Capillary permeability in rat hindquarters as determined by estimations of capillary reflection coefficients. , 1986, Acta physiologica Scandinavica.
[44] W. Deen. Hindered transport of large molecules in liquid‐filled pores , 1987 .
[45] S. Nathanson,et al. Insights into the mechanisms of lymph node metastasis , 2003, Cancer.
[46] J. Anderson,et al. Mechanism of osmotic flow in porous membranes. , 1974, Biophysical journal.
[47] Badrinath Roysam,et al. A 2-D/3-D model-based method to quantify the complexity of microvasculature imaged by in vivo multiphoton microscopy. , 2005, Microvascular research.
[48] R. Jain,et al. Intratumoral lymphatic vessels: a case of mistaken identity or malfunction? , 2002, Journal of the National Cancer Institute.
[49] P. Gullino,et al. Bulk transfer of fluid in the interstitial compartment of mammary tumors. , 1975, Cancer research.
[50] Ricky T. Tong. Dynamics of vascular normalization during anti-angiogenic therapy : implications for combination therapy , 2005 .
[51] R K Jain,et al. Geometric Resistance and Microvascular Network Architecture of Human Colorectal Carcinoma , 1997, Microcirculation.
[52] Rakesh K. Jain,et al. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy , 2001, Nature Medicine.